Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/1999
05/27/1999WO1999005270A3 Crustacean antimicrobial peptides, called penaiedines
05/27/1999WO1999003976A3 Method of treating leukocytes, leukocyte compositions and methods of use thereof
05/27/1999WO1998055495A3 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
05/27/1999WO1998049292A3 Polypeptides associated with activator receptors and their biological applications
05/27/1999DE19750702A1 Antisense oligonucleotides that bind to sequences encoding human tenascin for treating depigmentation, cancer, inflammation and cardiovascular disease
05/27/1999DE19750354A1 Covering an inductor molecule with a viral capsid, for more efficient transfection of cells
05/27/1999CA2310563A1 Vector for tissue-specific replication and gene expression
05/27/1999CA2310269A1 Immunoglobulin molecules having a synthetic variable region and modified specificity
05/27/1999CA2310255A1 Use of histamine for elevating blood histamine levels
05/27/1999CA2310233A1 Advanced glycation end-product intermediaries and post-amadori inhibition
05/27/1999CA2310228A1 Attaching substances to micro-organisms
05/27/1999CA2310097A1 Novel exendin agonist compounds
05/27/1999CA2309990A1 Modified antibodies with enhanced ability to elicit an anti-idiotype response
05/27/1999CA2309885A1 Recombinant allergen with reduced enzymatic activity
05/27/1999CA2309758A1 Reagents and methods useful for detecting diseases of the breast
05/27/1999CA2309756A1 Reagents and methods useful for detecting diseases of the breast
05/27/1999CA2309390A1 Cdk2 protein and cdk2 protein complexes
05/27/1999CA2309387A1 Method and kit for determining severe inflammatory reactions to mosquito bites
05/27/1999CA2309343A1 Toso
05/27/1999CA2309339A1 Transcriptionally regulated g protein-coupled receptor
05/27/1999CA2309164A1 Combination therapy for the treatment of aids
05/27/1999CA2308571A1 Single-chain bifunctional glycoprotein hormones
05/27/1999CA2308365A1 Dna19355 polypeptide, a tumor necrosis factor homolog
05/27/1999CA2306776A1 Methods for modulating nerve cell function
05/27/1999CA2306492A1 Human checkpoint kinase, hcds1, compositions and methods
05/27/1999CA2278030A1 Cyclic peptides and medicinal use thereof
05/26/1999EP0918091A1 A gene called XLIS and the XLIS gene product, called doublecortin and their applications
05/26/1999EP0918059A1 Substituted imidazoline derivatives, their preparation, their use, and pharmaceutical compositions containing them
05/26/1999EP0918054A1 A 1/2 sulfate of a ((S)-1-((S)-2-((trans-4-aminocyclohexylmethyl) carbamoyl) pyrrolidine-1-carbonyl)-2-iso-propylthio-2-methylpropyl) carbamic acid propyl ester
05/26/1999EP0917879A2 Procédé amélioré pour la stabilisation des protéines
05/26/1999EP0917878A1 Remedies for hepatitis
05/26/1999EP0917877A1 Remedies/preventives for viral infections, process for preparing the same, and method for preventing/treating viral infections
05/26/1999EP0917874A1 Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
05/26/1999EP0917581A1 Fusion polypeptides com0prising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses
05/26/1999EP0917579A1 Vertebrate telomerase genes and proteins and uses thereof
05/26/1999EP0917577A2 Herpes simplex virus icp4 is an inhibitor of apoptosis
05/26/1999EP0917576A1 Anti-herpesviral agents and assays therefor
05/26/1999EP0917575A1 Use of a lestr/fusin/cxcr4 receptor ligand chemokine (sdf-1) for treating or preventing hiv-type viral infection
05/26/1999EP0917574A2 BCL-x$g(g), A NOVEL BCL-x ISOFORM, AND USES RELATED THERETO
05/26/1999EP0917573A2 Use of recombinant myelin protein for treating t-cell-mediated autoimmune diseases of the peripheral nervous system
05/26/1999EP0917572A2 Secreted proteins and polynucleotides encoding them
05/26/1999EP0917571A1 Agouti-related gene
05/26/1999EP0917570A2 Mhc binding peptide oligomers and methods of use
05/26/1999EP0917569A2 Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase
05/26/1999EP0917567A1 Plasminogen activator capable of being activated by thrombin
05/26/1999EP0917539A1 Anticoagulant peptide fragments derived from apolipoprotein b-100
05/26/1999EP0917538A1 Eukaryotic cells expressing at their surface at least an hla-g isoform and their applications
05/26/1999EP0917537A1 Novel parathyroid hormone-related peptide analogs
05/26/1999EP0917535A1 Neuroactive peptide
05/26/1999EP0917472A1 Antiprotozoal composition
05/26/1999EP0917470A1 Method of treating hypertension using a composition containing a dried animal stomach mucosa and endogenous protease-inhibitor peptides
05/26/1999EP0917469A1 Methods for inducing bone formation
05/26/1999EP0917462A1 Cell adhesion inhibitors
05/26/1999EP0917460A1 Cyclosporin formulation
05/26/1999EP0917428A1 Hybrid matrix implants and explants
05/26/1999EP0859785A4 Cyclic peptide analogs of somatostatin
05/26/1999EP0833835A4 Obesity protein intermediates and their preparation and use
05/26/1999EP0804459A4 Therapeutic compound - fatty acid conjugates
05/26/1999EP0783316A4 Synthetic antibiotics
05/26/1999EP0772448A4 CYCLIC ANALOGS OF PTH AND PTHrP
05/26/1999EP0668910B1 Human neuropeptide y-y1 receptor
05/26/1999EP0630181B1 Nutritional product for trauma and surgery patients
05/26/1999EP0616641B1 Humanized b-b10, an anti-il2 receptor antibody
05/26/1999EP0610290B1 Manufacture of a medicament for treatment of ocular inflammation by blockage of cell adhesion molecules
05/26/1999EP0602173B1 Topical fibrinogen complex
05/26/1999EP0592673B1 6(r)-l-erythro-5,6,7,8-tetrahydrobiopterin receptor
05/26/1999EP0589993B1 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis
05/26/1999EP0453560B1 Localization and characterization of the wilms' tumor gene
05/26/1999CN1217750A Monoclonal antibody to CEA, Conjugates comprising said antibody, and their therapeutic use in ADEPT system
05/26/1999CN1217660A Method for retreatment of patients afflicted with Hepatitis C using consensus interferon
05/26/1999CN1217654A Process for production of powdered pulmoney surfactant preparations
05/26/1999CN1217653A Functionalized nanotubes
05/26/1999CN1217342A Colony stimulating factor for recombination of human granulocytes and medicinal composition thereof
05/26/1999CN1217339A Cellulose binding domain
05/26/1999CN1217334A Phosphoric-acid substituted benzo-aza-tropone-N-acetic acid derivative, preparing method and medicine thereof
05/26/1999CN1217327A D-proline derivative
05/25/1999US5907784 Method of making multi-layer gate structure with different stoichiometry silicide layers
05/25/1999US5907068 Peptide derivatives
05/25/1999US5907044 Solvent extraction, crystallization
05/25/1999US5907043 Coupling n-(4-methoxybenzoyl)-l-valyl-l-proline or a salt with 3-amino-4-methyl-1,1,1-trifluoro-2-pentanol forming (s)-1-(s)-2-(4-methoxybenzamido)-3-(2,2,2-trifluoro-1-hydroxy ethyl)propyl)pyrrolidine-2-carboxamide, oxidizing the product
05/25/1999US5907033 Anti-oncostatin M monoclonal antibodies
05/25/1999US5907032 Thrombin preparation
05/25/1999US5907030 Fatty acid derivatives of sulfhydryl containing peptides and proteins; for increased absorption of theraputic compounds across mucous membranes and skin
05/25/1999US5906988 Methods of treatment using ranolazine and related piperazine derivatives
05/25/1999US5906976 Method and composition for treating neuronal degeneration
05/25/1999US5906975 Conformationally stabilized cell adhesion peptides
05/25/1999US5906974 Hemoglobin therapy in hemodialysis
05/25/1999US5906938 Method of reconstituting hematopoietic cells using monoclonal antibodies to the stem cell factor receptor
05/25/1999US5906935 Cells transformed or transfected with HCMV US2-US5, US10-US11 genes
05/25/1999US5906923 ATPase inhibitor
05/25/1999US5906828 Cell growth substrates with tethered cell growth effector molecules
05/25/1999US5906821 Viral nucleotide sequences
05/25/1999US5906820 Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis
05/25/1999US5906819 Rho target protein Rho-kinase
05/25/1999US5906817 Biocompatible implant for the expression and in vivo secretion of a therapeutic substance
05/25/1999US5906816 Method for treatment of autoimmune diseases
05/25/1999US5906815 Administering an effective amount of interleukin-12 to the patient suffering from respiratory system disorders such as asthma; antiinflammatory agent; antiallergens
05/25/1999US5906811 Reducing free radical damage by tobacco or environmental pollutants administering a mixture of glutathione, ascorbic acid, selenium or selenium compound, a sulphur containing amino acid, as mouthwashes, mouth sprayer, nasal inhaler
05/25/1999CA2138977C Cosmetic containing phospholipids and fluorocarbon compounds
05/25/1999CA2127182C Method of improving efficiency in ruminants
1 ... 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 ... 3163